VOGLISTAR GM 2 10

About

Voglistar GM 2 is a comprehensive triple-combination medication designed for the robust management of type 2 diabetes mellitus. It typically combines Voglibose (an alpha-glucosidase inhibitor), Glimepiride (a sulfonylurea), and Metformin (a biguanide). Voglibose works by delaying carbohydrate absorption in the gut, reducing postprandial glucose spikes. Glimepiride stimulates insulin secretion from pancreatic beta cells, thereby lowering blood glucose. Metformin primarily reduces hepatic glucose production, decreases intestinal glucose absorption, and improves peripheral insulin sensitivity. This synergistic approach targets multiple pathophysiological defects of type 2 diabetes, providing extensive glycemic control. The combination is particularly useful for patients whose blood sugar levels are not adequately controlled by dual therapy or monotherapy, offering a powerful option to achieve and maintain target blood glucose levels. It is prescribed as an adjunct to diet and exercise to optimize glycemic outcomes.

Uses

• Management of type 2 diabetes mellitus.
• Improvement of glycemic control in adults.
• Used as an adjunct to diet and exercise.
• When dual therapy is inadequate.

Directions For Use

Take this medication orally as directed by your physician, usually with meals to minimize gastrointestinal side effects. Do not crush or chew the tablet.

Benefits

• Provides triple-action glycemic control.
• Targets multiple pathways of glucose regulation.
• Significantly lowers fasting and post-meal blood sugar.
• Improves insulin secretion and sensitivity.
• Reduces hepatic glucose production.
• Convenient fixed-dose combination.

Side Effects

• Hypoglycemia
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Flatulence
• Headache
• Dizziness
• Metallic taste
• Skin rash
• Lactic acidosis (rare, but serious with Metformin)
• Vitamin B12 deficiency (long-term Metformin use)

Safety Measures

• Alcohol - Avoid excessive alcohol consumption as it can increase the risk of lactic acidosis (due to Metformin) and hypoglycemia (due to Glimepiride).
• Pregnancy - Consult your doctor. This medication is generally not recommended during pregnancy due to potential risks to the fetus and lack of established safety.
• Breastfeeding - Consult your doctor. Components of this medication may pass into breast milk, and its use during breastfeeding should be carefully considered.
• Liver - Use with extreme caution in patients with liver impairment. Metformin is contraindicated in severe hepatic dysfunction due to increased risk of lactic acidosis.
• Kidney - Use with extreme caution and dose adjustment in patients with kidney impairment. Metformin is contraindicated in severe renal impairment due to accumulation and increased risk of lactic acidosis.
• Lung - Use with caution in patients with severe lung conditions, as these may predispose to lactic acidosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.